The 20 Best Nonalcoholic Steatohepatitis (NASH) Doctors Near Me in Bronx, NY

Dr. Sanjaya K. Satapathy is the medical director of the Center for Liver Disease and Transplantation at the Northwell Transplant Institute, program director of Northwell's Transplant Hepatology Fellowship, and professor of medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.His path to medicine began in India, where he was inspired by his father an engineer with a passion for homeopathy to pursue a career in healthcare. He earned his medical degree from Veer Surendra Sai Medical College, followed by fellowship training in gastroenterology and hepatology in the early 2000s. During that time, he witnessed the profound need for liver transplantation in India, where access remained scarce.While presenting his research at a conference in the United States, Dr. Satapathy was drawn to the opportunities and possibilities for advancing transplantation in America. He decided to continue his career in the United States, completing additional residency and fellowship training before serving as a transplant hepatologist in Memphis. In 2019, he was recruited to Northwell.It was a dream to begin from zero and build a transplant program that could be a model not just for the area or the state, but for the country, says Dr. Satapathy. Within only a few years, we've been able to achieve that goal, because Northwell has all the elements and resources to be one of the best programs in the nation. The expertise we have is unparalleled, with a collaborative team that encompasses all levels of care.The program was founded just in time for a huge surge in demand for liver transplants in the area, he adds. Liver disease and other liver issues are on the rise, making the need for an extensive program crucial for those in the New York region. Part of the program's strength is innovation. For example, Northwell is utilizing an approach that allows donated organs to be safely preserved for a longer period of time, which means needed organs can travel longer distances even from as far away as Hawaii. Northwell is also running several clinical trials on transplant medications and operates a robust transplant hepatology fellowship program to train the next generation of doctors a program Dr. Satapathy launched.I'm passionate about this work, and particularly about my patients, he says. I see every patient as my family, and my focus is on what I can do next to help them. Dr. Satapathy is rated as an Elite provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Spontaneous Bacterial Peritonitis, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Endoscopy. Dr. Satapathy is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Gastroenterology, and American Board Of Internal Medicine/Transplant Hepatology.

Scott Friedman is a Gastroenterologist practicing medicine in New York, New York. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Cirrhosis, Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Hepatectomy.

Dr. Utpal Pajvani, Associate Professor of Medicine in the Division of Endocrinology at Columbia University, is a physician-scientist with clinical and research focus in Type 2 Diabetes and related metabolic diseases. He graduated from the Massachusetts Institute of Technology with a degree in Biology in 1996, then earned MS (2001), MD (2005) and PhD (Department of Cell Biology, 2005) degrees from the Albert Einstein College of Medicine. Dr. Pajvani completed his internship and residency training and is board certified in Internal Medicine (2007) and fellowship in Endocrinology, Diabetes & Metabolism (2011), both at the Columbia University Medical Center.Dr. Pajvani has been on the faculty of Columbia University since 2011. He is a teaching attending on the inpatient and outpatient Endocrinology and General Medicine services of the New York Presbyterian Hospital, and sees patients at the Naomi Berrie Diabetes Center at Columbia University. Dr. Pajvani is rated as an Advanced provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Obesity, and Type 2 Diabetes (T2D). Dr. Pajvani is board certified in Internal Medicine and Endocrinology, Diabetes And Metabolism. Dr. Pajvani is currently accepting new patients.

Dr. Tabas received his medical degree and his doctorate in biochemistry from Washington University in St. Louis, Missouri. He then completed an internship and residency in internal medicine and a fellowship in endocrinology and metabolism at Columbia University Medical Center in New York City. During that period, Dr. Tabas also conducted a postdoctoral fellowship in the laboratory of Dr. Alan Tall in the Department of Medicine at Columbia University. He joined the Columbia faculty in 1985 and is currently the Richard J. Stock Professor and Vice-Chair of Research in the Department of Medicine and Professor of Pathology and Cell Biology (in Physiology and Cellular Biophysics).Dr. Tabas' honor include the American Heart Association Established Investigator Award, the Columbia University Doctor Harold and Golden Lamport Research Award, the American Heart Association/ATVB Council Special Recognition Award, the Richard J. Stock Professorship in the Department of Medicine of Columbia University, and the 2011 Alumni Achievement Award from Washington University School of Medicine. He was elected to both the Society for Clinical Investigation and the Association of American Physicians. Dr. Tabas is rated as a Distinguished provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Non-Alcoholic Fatty Liver Disease, Obesity, and Maturity Onset Diabetes of the Young. Dr. Tabas is board certified in Internal Medicine and Endocrinology.

Patrick Northup is a Hepatologist and a Transplant Surgeon practicing medicine in New York, New York. Dr. Northup is rated as a Distinguished provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Ascites, Nonalcoholic Steatohepatitis (NASH), Liver Transplant, and Endoscopy. Dr. Northup is board certified in American Board Of Internal Medicine. Dr. Northup is currently accepting new patients.

Christian Kuntzen is a Hepatologist and a Gastroenterologist practicing medicine in Manhasset, New York. Dr. Kuntzen is rated as a Distinguished provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Ascites, Visceromegaly, Gastrectomy, and Colonoscopy. Dr. Kuntzen is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine/Gastroenterology.

Dr. Machineni obtained his medical degree from the All India Institute of Medical Sciences in New Delhi, followed by a residency in internal medicine at the State University of New York at  Buffalo. He served as chief resident and primary care teaching physician at Buffalo General Hospital. He subsequently completed a clinical and research fellowship in obesity medicine and metabolism at Massachusetts General Hospital/ Harvard Medical School and stayed on as an instructor. Dr. Machineni studied energy balance and body fat regulation in animal models allowing the interpretation of clinical research findings and phenotypes in the context of physiology. Dr. Machineni is rated as an Experienced provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Obesity, Obesity in Children, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Gastric Bypass.

Shivani Agarwal, MD, MPH, is Director of the SEAD (Supporting Emerging Adults with Diabetes) program at Montefiore and an Assistant Professor of Medicine at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2018, her clinical focus has been on the treatment of type 1 and type 2 diabetes in patients aged 18 to 35 years old. Dr. Agarwal is rated as undefined provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). Her clinical expertise encompasses Type 1 Diabetes (T1D), Non-Alcoholic Fatty Liver Disease, and Nonalcoholic Steatohepatitis (NASH).

Dr. Nir Barzilai is the director of the Institute for Aging Research at the Albert Einstein College of Medicine and the Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of the National Institutes of Health’s (NIH) Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is the Ingeborg and Ira Leon Rennert Chair of Aging Research, professor in the Departments of Medicine and Genetics, and member of the Diabetes Research Center and of the Divisions of Endocrinology & Diabetes and Geriatrics. Dr. Barzilai is rated as undefined provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Diabetic Retinopathy, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Abdominal Obesity Metabolic Syndrome.

Clara Y. Tow, MD, is Clinical Site Director, Hepatology, Associate Program Director, Gastroenterology & Liver Diseases Fellowship Program, Co-Course Director, Gastroenterology & Hepatology Systems Course and Assistant Professor, Medicine at Montefiore Einstein. Dr. Tow specializes in the treatment of complications of advanced liver diseases, liver cancer and liver transplant. She believes every patient is an integral part of the Montefiore Einstein family and that patient knowledge is power. Her goal is to provide patients and their families with the best medical care embedded in kindness, dignity and respect. Dr. Tow is rated as an Experienced provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Hepatitis, Hepatitis C, Alcoholic Cirrhosis, Liver Failure, and Liver Transplant.

Jonathan M. Schwartz is a board Certified Transplant Hepatologist.  He is a graduate of Tel Aviv University, Sackler School of Medicine. He was an Internal Medicine Resident at Albert Einstein College of Medicine and a Fellow in Gastroenterology/Transplant Hepatology at the University of Washington in Seattle.  He returned to New York in 2011 from Portland, Oregon where he served as an Associate Professor of Medicine at Oregon Health and Sciences University. Dr. Schwartz is rated as an Experienced provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Hepatitis, Primary Biliary Cholangitis, Reynolds Syndrome, and Budd-Chiari Syndrome. Dr. Schwartz is board certified in American Board Of IM/Gastroenterology.

Harvey Rosenberg is a Gastroenterologist practicing medicine in Bronx, New York. Dr. Rosenberg is rated as undefined provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). His clinical expertise encompasses Gastrointestinal Bleeding, Familial Adenomatous Polyposis, Esophageal Varices, Gastrectomy, and Colonoscopy.

Justin Mathew is an Endocrinologist practicing medicine in Bronx, New York. Dr. Mathew is rated as undefined provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). His clinical expertise encompasses Thyroid Storm, Type 1 Diabetes (T1D), Hyperthyroidism, and Hyperparathyroidism.

Anjali Manavalan is an Endocrinologist practicing medicine in Bronx, New York. Dr. Manavalan is rated as undefined provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). Her clinical expertise encompasses Ectopic Cushing's syndrome, Panhypopituitarism, Low Blood Sugar, and Neurohypophyseal Diabetes Insipidus.

Dr. Sandra Aleksic is an Assistant Professor in Department of Medicine, Division of Endocrinology and Geriatrics. She earned her medical degree from the University of Belgrade Faculty of Medicine in Serbia. She completed residency in internal medicine at Rutgers New Jersey Medical School and fellowship in endocrinology, diabetes and metabolism at Montefiore Medical Center/Albert Einstein College of Medicine. She earned a Master of Science in Clinical Research Methods through Einstein’s Clinical Research Training Program. She is the recipient of a Career Development Award from the Einstein/Montefiore Institute for Clinical and Translational Research, Resnick Emerging Scholar in Aging Research Award and Paul B. Beeson Emerging Leaders Career Development Award in Aging. Dr. Aleksic is rated as undefined provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). Her clinical expertise encompasses Low Blood Sugar, Type 2 Diabetes (T2D), Isolated Hypogonadotropic Hypogonadism, and Hypogonadotropic Hypogonadism.

Allan W. Wolkoff, MD, is Chief, Hepatology, Herman Lopata Chair in Liver Disease Research and Professor, Medicine and Developmental & Molecular Biology at Montefiore Einstein. His clinical focus centers on diseases of the liver and biliary tract, including chronic liver disease, fatty liver disease, hepatitis, inheritable disorders of the liver, drug toxicity and unexplained jaundice. Dr. Wolkoff is rated as undefined provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). His clinical expertise encompasses Hepatitis C, Hepatitis, Cirrhosis, and Non-Alcoholic Fatty Liver Disease.

Dr. Preeti Kishore is a Professor in the Division of Endocrinology.  She is the site director for the Einstein/Montefiore Endocrinology Fellowship Program at Jacobi Medical Center. As Chief of the Endocrinology Division at Jacobi she is responsible for the clinical endocrine inpatient and outpatient operations at Jacobi and North Central Bronx Hospitals. She actively participates in the teaching of endocrinology fellows, internal medicine residents and Einstein medical students. Her education philosophy is to empower learners to drive their own educational goals/learning. She is interested in the use of diabetes technology to manage low health literacy patients with diabetes. She is also the Director of the Weight Management Program at Jacobi. Dr. Kishore is rated as undefined provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). Her clinical expertise encompasses Hyperlipoproteinemia Type 5, Type 2 Diabetes (T2D), Diabetic Ketoacidosis, and Obesity.

Rebecca Roediger, MD, is an attending physician at Montefiore Einstein. Her clinical focus centers on transplant hepatology, alcohol-associated liver disease and viral hepatitis. Dr. Roediger is rated as an Experienced provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Macroamylasemia, Non-Alcoholic Fatty Liver Disease, Visceromegaly, and Hepatitis.

Liver regeneration is critical for health. We focus on physiology of liver regeneration during development, early childhood and adulthood to inform mechanistic disruptions in diseases. The latter ranges from acute liver failure, effects of drugs, toxins, alcohol, virus hepatitis, obesity-related metabolic (or nonalcoholic) liver disease, chronic hepatitis, e.g., Wilson disease with copper toxicosis, and allograft rejection. The mechanisms concerning DNA damage response directed by ATM gene and downstream partners are of considerable interest to us. Dr. Gupta is rated as an Experienced provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Liver Failure, Hepatocerebral Degeneration, Wilson Disease, and Non-Alcoholic Fatty Liver Disease.

Jill P. Crandall, MD, is Professor and Jacob A. and Jeanne E. Barkey Chair in Medicine and Chief, Division of Endocrinology at Montefiore Einstein. Her clinical focus is on the treatment of types 1 and type 2 diabetes as well as related metabolic disorders. Dr. Crandall is rated as undefined provider by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Low Testosterone, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Type 1 Diabetes (T1D), and Hormone Replacement Therapy (HRT).